Skip to main content

NEW YORK (TheStreet) -- Shares of Smith & Nephew plc (SNN) - Get Smith & Nephew Plc Report are higher by 10.44% to $38.41 on heavy volume in mid-afternoon trading on Tuesday, after Bloomberg reported that Stryker Corp. (SYK) - Get Stryker Corporation Report is planning to issue a takeover offer for the U.K-based medical device maker.

Stryker, a U.S producer of surgical instruments, is said to be offering a "significant premium" to Smith & Nephew's current share price, sourced told Bloomberg.

Stryker is not planning a tax inversion the sources told Bloomberg, due to the risk, and limited tax benefits.

Exclusive Report:Jim Cramer's Best Stocks For 2015

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

The sources added that the bid is still being finalized, and that the timing of the offer could change, or no offer could be issued.

TheStreet Recommends

Companies that produce medical devices are looking to merge as insurers and hospitals are seeking out better prices from suppliers in order to overcome rising costs, Bloomberg noted.

Separately, TheStreet Ratings team rates SMITH & NEPHEW PLC as a Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation:

"We rate SMITH & NEPHEW PLC (SNN) a BUY. This is driven by a few notable strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income."

Highlights from the analysis by TheStreet Ratings Team goes as follows:

  • SNN's revenue growth has slightly outpaced the industry average of 7.2%. Since the same quarter one year prior, revenues rose by 11.8%. This growth in revenue does not appear to have trickled down to the company's bottom line, displayed by a decline in earnings per share.
  • The current debt-to-equity ratio, 0.50, is low and is below the industry average, implying that there has been successful management of debt levels.
  • The gross profit margin for SMITH & NEPHEW PLC is currently very high, coming in at 84.93%. It has increased from the same quarter the previous year. Regardless of the strong results of the gross profit margin, the net profit margin of 8.88% trails the industry average.
  • Looking at where the stock is today compared to one year ago, we find that it is not only higher, but it has also clearly outperformed the rise in the S&P 500 over the same period, despite the company's weak earnings results. Turning our attention to the future direction of the stock, it goes without saying that even the best stocks can fall in an overall down market. However, in any other environment, this stock still has good upside potential despite the fact that it has already risen in the past year.
  • You can view the full analysis from the report here: SNN Ratings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.